Search

Search Constraints

You searched for: Author/Creator Zuin, Massimo

Search Results

2. Modeling cost‐effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real‐life cohort. Issue 6 (30th October 2017)

3. Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study. Issue 2 (February 2020)

5. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort. Issue 12 (December 2021)

6. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial. (December 2022)

7. Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d-penicillamine. Issue 9 (29th April 2022)

8. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)

9. Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid. (23rd August 2022)

10. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10215 (14th December 2019)